PPA
SYRS

Parametric Portfolio Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Parametric Portfolio Associates’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$14K Sell
1,187
-769
-39% -$13.8K ﹤0.01% 3665
2021
Q4 		$64K Sell
1,956
-433
-18% -$17.5K ﹤0.01% 3589
2021
Q3 		$107K Buy
2,389
+478
+25% +$23.3K ﹤0.01% 3527
2021
Q2 		$104K Buy
+1,911
New +$113K ﹤0.01% 3478
2021
Q1 		– Sell
-1,889
Closed -$205K – 4089
2020
Q4 		$205K Sell
1,889
-3,264
-63% -$298K ﹤0.01% 3765
2020
Q3 		$456K Buy
+5,153
New +$585K ﹤0.01% 3317

Other funds holding SYRS

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Parametric Portfolio Associates's SYRS Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Syros Pharmaceuticals, Inc. Common Stock (SYRS) stake by 39% in Q1 2022, selling an estimated $13.8K and leaving 1,187 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Parametric Portfolio Associates first reported a position in SYRS in Q3 2020 and has held it in 6 quarters since. The position peaked at $456K in Q3 2020. 94 funds tracked by Wall St. Rank hold SYRS as of Q1 2022.

  • Parametric Portfolio Associates held 1,187 shares of Syros Pharmaceuticals, Inc. Common Stock worth $14K as of Q1 2022.
  • Parametric Portfolio Associates sold 769 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $13.8K.
  • Syros Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3665 holding.
  • Parametric Portfolio Associates first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q3 2020 and has held it in 6 quarters since.
  • Parametric Portfolio Associates's Syros Pharmaceuticals, Inc. Common Stock position peaked at $456K in Q3 2020.
  • 94 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.